Playing hide and seek: How glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection

Viruses

Volumn 6, Issue 3, 2014, Pages 1294-1316

  Tate, Michelle D ^a   Job, Emma R ^b   Deng, Yi Mo ^c   Gunalan, Vithiagaran ^d   Maurer Stroh, Sebastian ^d,e,f   Reading, Patrick C ^b,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^d BIOINFORMATICS INSTITUTE   (Singapore)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^f MINISTRY OF HEALTH   (Singapore)

Author keywords

Glycosylation; Immune evasion; Influenza virus; Lectin

Indexed keywords

EPITOPE; GLYCAN; HN PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; LECTIN; MANNOSE BINDING LECTIN; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; NEUTRALIZING ANTIBODY; OLIGOSACCHARIDE; SURFACTANT ASSOCIATED PROTEIN;

ADAPTIVE IMMUNITY; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; HUMORAL IMMUNITY; IMMUNE EVASION; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS A; NONHUMAN; PHYLOGENY; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADAPTIVE IMMUNITY; GLYCOSYLATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; ORTHOMYXOVIRIDAE; VIRUS ATTACHMENT;

EID: 84897878395     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6031294     Document Type: Review

References (128)

1. Kornfeld, R.; Kornfeld, S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 1985, 54, 631-664.
2. Deom, C.M.; Schulze, I.T. Oligosaccharide composition of an influenza virus hemagglutinin with host-determined binding properties. J. Biol. Chem. 1985, 260, 14771-14774.
3. Nakamura, K.; Compans, R.W. Host cell- and virus strain-dependent differences in oligosaccharides of hemagglutinin glycoproteins of influenza a viruses. Virology 1979, 95, 8-23.
4. Basak, S.; Pritchard, D.G.; Bhown, A.S.; Compans, R.W. Glycosylation sites of influenza viral glycoproteins: Characterization of tryptic glycopeptides from the a/ussr(h1n1) hemagglutinin glycoprotein. J. Virol. 1981, 37, 549-558.
5. Ward, C.W.; Dopheide, T.A. Amino acid sequence and oligosaccharide distribution of the haemagglutinin from an early hong kong influenza virus variant a/aichi/2/68 (x-31). Biochem. J. 1981, 193, 953-962.
6. Compans, R.W.; Pinter, A. Incorporation of sulfate into influenza virus glycoproteins. Virology 1975, 66, 151-160.
7. Karaivanova, V.K.; Spiro, R.G. Sulphation of n-linked oligosaccharides of vesicular stomatitis and influenza virus envelope glycoproteins: Host cell specificity, subcellular localization and identification of substituted saccharides. Biochem. J. 1998, 329, 511-518.
8. Kaverin, N.V.; Klenk, H.D. Strain-specific differences in the effect of influenza a virus neuraminidase on vector-expressed hemagglutinin. Arch. Virol. 1999, 144, 781-786.
9. Basak, S.; Tomana, M.; Compans, R.W. Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase. Virus Res. 1985, 2, 61-68.
10. Job, E.R.; Deng, Y.M.; Barfod, K.K.; Tate, M.D.; Caldwell, N.; Reddiex, S.; Maurer-Stroh, S.; Brooks, A.G.; Reading, P.C. Addition of glycosylation to influenza a virus hemagglutinin modulates antibody-mediated recognition of h1n1 2009 pandemic viruses. J. Immunol. 2013, 190, 2169-2177.
11. Blake, T.A.; Williams, T.L.; Pirkle, J.L.; Barr, J.R. Targeted n-linked glycosylation analysis of h5n1 influenza hemagglutinin by selective sample preparation and liquid chromatography/tandem mass spectrometry. Anal. Chem. 2009, 81, 3109-3118.
12. Kasturi, L.; Eshleman, J.R.; Wunner, W.H.; Shakin-Eshleman, S.H. The hydroxy amino acid in an asn-x-ser/thr sequon can influence n-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein. J. Biol. Chem. 1995, 270, 14756-14761.
13. Mellquist, J.L.; Kasturi, L.; Spitalnik, S.L.; Shakin-Eshleman, S.H. The amino acid following an asn-x-ser/thr sequon is an important determinant of n-linked core glycosylation efficiency. Biochemistry 1998, 37, 6833-6837.
14. Sun, S.; Wang, Q.; Zhao, F.; Chen, W.; Li, Z. Glycosylation site alteration in the evolution of influenza a (h1n1) viruses. PLoS One 2011, 6, e22844.
15. Abe, Y.; Takashita, E.; Sugawara, K.; Matsuzaki, Y.; Muraki, Y.; Hongo, S. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza a/h3n2 virus hemagglutinin. J. Virol. 2004, 78, 9605-9611.
16. Schulze, I.T. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J. Infect. Dis. 1997, 176, S24-S28.
17. Wagner, R.; Wolff, T.; Herwig, A.; Pleschka, S.; Klenk, H.D. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: A study by reverse genetics. J. Virol. 2000, 74, 6316-6323.
18. Roberts, P.C.; Garten, W.; Klenk, H.D. Role of conserved glycosylation sites in maturation and transport of influenza a virus hemagglutinin. J. Virol. 1993, 67, 3048-3060.
19. Daniels, R.; Kurowski, B.; Johnson, A.E.; Hebert, D.N. N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol. Cell 2003, 11, 79-90.
20. Nobusawa, E.; Aoyama, T.; Kato, H.; Suzuki, Y.; Tateno, Y.; Nakajima, K. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza a viruses. Virology 1991, 182, 475-485.
21. Ohuchi, R.; Ohuchi, M.; Garten, W.; Klenk, H.D. Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity. J. Virol. 1997, 71, 3719-3725.
22. Gallagher, P.J.; Henneberry, J.M.; Sambrook, J.F.; Gething, M.J. Glycosylation requirements for intracellular transport and function of the hemagglutinin of influenza virus. J. Virol. 1992, 66, 7136-7145.
23. Blackburne, B.P.; Hay, A.J.; Goldstein, R.A. Changing selective pressure during antigenic changes in human influenza h3. PLoS Pathog. 2008, 4, e1000058.
24. Cherry, J.L.; Lipman, D.J.; Nikolskaya, A.; Wolf, Y.I. Evolutionary dynamics of n-glycosylation sites of influenza virus hemagglutinin. PLoS Curr. Influenza 2009, RRN1001.
25. Das, S.R.; Puigbo, P.; Hensley, S.E.; Hurt, D.E.; Bennink, J.R.; Yewdell, J.W. Glycosylation focuses sequence variation in the influenza a virus h1 hemagglutinin globular domain. PLoS Pathog. 2010, 6, e1001211.
26. Igarashi, M.; Ito, K.; Kida, H.; Takada, A. Genetically destined potentials for n-linked glycosylation of influenza virus hemagglutinin. Virology 2008, 376, 323-329.
27. Zhang, M.; Gaschen, B.; Blay, W.; Foley, B.; Haigwood, N.; Kuiken, C.; Korber, B. Tracking global patterns of n-linked glycosylation site variation in highly variable viral glycoproteins: Hiv, siv, and hcv envelopes and influenza hemagglutinin. Glycobiology 2004, 14, 1229-1246.
28. Palese, P.; Wang, T.T. Why do influenza virus subtypes die out? A hypothesis. MBio 2011, 2, e00150-e00151.
29. Job, E.R.; Deng, Y.M.; Tate, M.D.; Bottazzi, B.; Crouch, E.C.; Dean, M.M.; Mantovani, A.; Brooks, A.G.; Reading, P.C. Pandemic h1n1 influenza a viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J. Immunol. 2010, 185, 4284-4291.
30. Reid, A.H.; Fanning, T.G.; Hultin, J.V.; Taubenberger, J.K. Origin and evolution of the 1918 Spanish Influenza virus hemagglutinin gene. Proc. Natl. Acad. Sci. USA 1999, 96, 1651-1656.
31. Wei, C.J.; Boyington, J.C.; Dai, K.; Houser, K.V.; Pearce, M.B.; Kong, W.P.; Yang, Z.Y.; Tumpey, T.M.; Nabel, G.J. Cross-neutralization of 1918 and 2009 influenza viruses: Role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2010, 2, 24ra21.
32. Medina, R.A.; Stertz, S.; Manicassamy, B.; Zimmermann, P.; Sun, X.; Albrecht, R.A.; Uusi-Kerttula, H.; Zagordi, O.; Belshe, R.B.; Frey, S. E.; et al. Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the h1n1 influenza viruses. Sci. Transl. Med. 2013, 5, 170-187.
33. Tsuchiya, E.; Sugawara, K.; Hongo, S.; Matsuzaki, Y.; Muraki, Y.; Li, Z.N.; Nakamura, K. Antigenic structure of the haemagglutinin of human influenza a/h2n2 virus. J. Gen. Virol. 2001, 82, 2475-2484.
34. Tsuchiya, E.; Sugawara, K.; Hongo, S.; Matsuzaki, Y.; Muraki, Y.; Li, Z.N.; Nakamura, K. Effect of addition of new oligosaccharide chains to the globular head of influenza a/h2n2 virus haemagglutinin on the intracellular transport and biological activities of the molecule. J. Gen. Virol. 2002, 83, 1137-1146.
35. NetNGlyc. Available online: http://www.cbs.dtu.dk/services/NetNGlyc/ (accessed on 14 November 2013).
36. Glyprot. Available online: http://ww.glycosciences.de/modeling/glyprot/ (accessed on 4 December 2013).
37. Persistence of Vision Raytracer, version 3.7; Persistence of Vision Pty. Ltd: Williamstown, Victoria, Australia, 2004. Available online: http://www.povray.org/ (accessed on 4 December 2013).
38. Chen, W.; Zhong, Y.; Qin, Y.; Sun, S.; Li, Z. The evolutionary pattern of glycosylation sites in influenza virus (h5n1) hemagglutinin and neuraminidase. PLoS One 2012, 7, e49224.
39. Panaampon, J.; Ngaosuwankul, N.; Suptawiwat, O.; Noisumdaeng, P.; Sangsiriwut, K.; Siridechadilok, B.; Lerdsamran, H.; Auewarakul, P.; Pooruk, P.; Puthavathana, P. A novel pathogenic mechanism of highly pathogenic avian influenza h5n1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors. PLoS One 2012, 7, e36318.
40. Kageyama, T.; Fujisaki, S.; Takashita, E.; Xu, H.; Yamada, S.; Uchida, Y.; Neumann, G.; Saito, T.; Kawaoka, Y.; Tashiro, M. Genetic analysis of novel avian a(h7n9) influenza viruses isolated from patients in china, february to april 2013. Euro. Surveill. 2013, 18, 20453.
41. Gottschalk, A.; Belyavin, G.; Biddle, F. Glycoproteins as influenza virus hemagglutinin inhibitors and as cellular receptors. In Glycoproteins. Their Composition, Structure and Function; Gottschalk, A., Ed.; Elsevier Science Publishing: New York, NY, USA,1972; pp. 1082-1096.
42. Ng, W.C.; Tate, M.D.; Brooks, A.G.; Reading, P.C. Soluble host defense lectins in innate immunity to influenza virus. J. Biomed. Biotechnol. 2012, 2012, 732191.
43. Anders, E.M.; Hartley, C.A.; Jackson, D.C. Bovine and mouse serum beta inhibitors of influenza a viruses are mannose-binding lectins. Proc. Natl. Acad. Sci. USA 1990, 87, 4485-4489.
44. Hartley, C.A.; Jackson, D.C.; Anders, E.M. Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: Identification of bovine serum beta inhibitor as conglutinin. J. Virol. 1992, 66, 4358-4363.
45. Drickamer, K. C-type lectin-like domains. Curr. Opin. Struct. Biol. 1999, 9, 585-590.
46. Crouch, E.C. Collectins and pulmonary host defense. Am. J. Respir. Cell Mol. Biol. 1998, 19, 177-201.
47. Reading, P.C.; Morey, L.S.; Crouch, E.C.; Anders, E.M. Collectin-mediated antiviral host defense of the lung: Evidence from influenza virus infection of mice. J. Virol. 1997, 71, 8204-8212.
48. Tate, M.D.; Schilter, H.C.; Brooks, A.G.; Reading, P.C. Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza a virus. Viral. Immunol. 2011, 24, 77-88.
49. Tate, M.D.; Brooks, A.G.; Reading, P.C. Inhibition of lectin-mediated innate host defences in vivo modulates disease severity during influenza virus infection. Immunol. Cell Biol. 2011, 89, 482-491.
50. Hartshorn, K.L.; White, M.R.; Mogues, T.; Ligtenberg, T.; Crouch, E.; Holmskov, U. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza a viruses. Am. J. Physiol. Lung. Cell Mol. Physiol. 2003, 285, L1066-L1076.
51. White, M.R.; Tecle, T.; Crouch, E.C.; Hartshorn, K.L. Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid. Am. J. Physiol. Lung. Cell Mol. Physiol. 2007, 293, L1293-L1299.
52. Fidler, K.J.; Hilliard, T.N.; Bush, A.; Johnson, M.; Geddes, D.M.; Turner, M.W.; Alton, E.W.; Klein, N.J.; Davies, J.C. Mannose-binding lectin is present in the infected airway: A possible pulmonary defence mechanism. Thorax 2009, 64, 150-155.
53. LeVine, A.M.; Whitsett, J.A.; Hartshorn, K.L.; Crouch, E.C.; Korfhagen, T.R. Surfactant protein d enhances clearance of influenza a virus from the lung in vivo. J. Immunol. 2001, 167, 5868-5873.
54. Hawgood, S.; Brown, C.; Edmondson, J.; Stumbaugh, A.; Allen, L.; Goerke, J.; Clark, H.; Poulain, F. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J. Virol. 2004, 78, 8565-8572.
55. Vigerust, D.J.; Ulett, K.B.; Boyd, K.L.; Madsen, J.; Hawgood, S.; McCullers, J.A. N-linked glycosylation attenuates h3n2 influenza viruses. J. Virol. 2007, 81, 8593-8600.
56. Zhang, L.; Hartshorn, K.L.; Crouch, E.C.; Ikegami, M.; Whitsett, J.A. Complementation of pulmonary abnormalities in sp-d(-/-) mice with an sp-d/conglutinin fusion protein. J. Biol. Chem. 2002, 277, 22453-22459.
57. Chang, W.C.; White, M.R.; Moyo, P.; McClear, S.; Thiel, S.; Hartshorn, K.L.; Takahashi, K. Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza a virus infection. BMC Immunol. 2010, 11, 64.
58. Hansen, S.; Selman, L.; Palaniyar, N.; Ziegler, K.; Brandt, J.; Kliem, A.; Jonasson, M.; Skjoedt, M.O.; Nielsen, O.; Hartshorn K.; et al. Collectin 11 (cl-11, cl-k1) is a masp-1/3-associated plasma collectin with microbial-binding activity. J. Immunol. 2010, 185, 6096-6104.
59. Hartshorn, K.L.; Holmskov, U.; Hansen, S.; Zhang, P.; Meschi, J.; Mogues, T.; White, M.R.; Crouch, E.C. Distinctive anti-influenza properties of recombinant collectin 43. Biochem. J. 2002, 366, 87-96.
60. Hartshorn, K.L.; White, M.R.; Smith, K.; Sorensen, G.; Kuroki, Y.; Holmskov, U.; Head, J.; Crouch, E.C. Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: Dissociation of mannan-binding and antiviral activity. Scand. J. Immunol. 2010, 72, 22-30.
61. Hartshorn, K.L.; Sastry, K.; Brown, D.; White, M.R.; Okarma, T.B.; Lee, Y.M.; Tauber, A.I. Conglutinin acts as an opsonin for influenza a viruses. J. Immunol. 1993, 151, 6265-6273.
62. Tate, M.D.; Brooks, A.G.; Reading, P.C. Specific sites of n-linked glycosylation on the hemagglutinin of h1n1 subtype influenza a virus determine sensitivity to inhibitors of the innate immune system and virulence in mice. J. Immunol. 2011, 187, 1884-1894.
63. Tate, M.D.; Job, E.R.; Brooks, A.G.; Reading, P.C. Glycosylation of the hemagglutinin modulates the sensitivity of h3n2 influenza viruses to innate proteins in airway secretions and virulence in mice. Virology 2011, 413, 84-92.
64. Caton, A.J.; Brownlee, G.G.; Yewdell, J.W.; Gerhard, W. The antigenic structure of the influenza virus a/pr/8/34 hemagglutinin (h1 subtype). Cell 1982, 31, 417-427.
65. Sun, X.; Jayaraman, A.; Maniprasad, P.; Raman, R.; Houser, K.V.; Pappas, C.; Zeng, H.; Sasisekharan, R.; Katz, J.M.; Tumpey, T.M. N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal h1n1 influenza a viruses. J. Virol. 2013, 87, 8756-8766.
66. Hartshorn, K.L.; Webby, R.; White, M.R.; Tecle, T.; Pan, C.; Boucher, S.; Moreland, R.J.; Crouch, E.C.; Scheule, R.K. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein d. Respir. Res. 2008, 9, 65.
67. Tokunaga, H.; Ushirogawa, H.; Ohuchi, M. The pandemic (h1n1) 2009 influenza virus is resistant to mannose-binding lectin. Virol. J. 2011, 8, 50.
68. Qi, L.; Kash, J.C.; Dugan, V.G.; Jagger, B.W.; Lau, Y.F.; Sheng, Z.M.; Crouch, E.C.; Hartshorn, K.L.; Taubenberger, J.K. The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein d binding. Virology 2011, 412, 426-434.
69. Reading, P.C. University of Melbourne, Melbourne, Australia. Unpublished work, 2014.
70. Ioannidis, L.J.; Verity, E.E.; Crawford, S.; Rockman, S.P.; Brown, L.E. Abortive replication of influenza virus in mouse dendritic cells. J. Virol. 2012, 86, 5922-5925.
71. Hargadon, K.M.; Zhou, H.; Albrecht, R.A.; Dodd, H.A.; Garcia-Sastre, A.; Braciale, T.J. Major histocompatibility complex class ii expression and hemagglutinin subtype influence the infectivity of type a influenza virus for respiratory dendritic cells. J. Virol. 2011, 85, 11955-11963.
72. Hao, X.; Kim, T.S.; Braciale, T.J. Differential response of respiratory dendritic cell subsets to influenza virus infection. J. Virol. 2008, 82, 4908-4919.
73. Rodgers, B.; Mims, C.A. Interaction of influenza virus with mouse macrophages. Infect. Immun. 1981, 31, 751-757.
74. Wells, M.A.; Albrecht, P.; Daniel, S.; Ennis, F.A. Host defense mechanisms against influenza virus: Interaction of influenza virus with murine macrophages in vitro. Infect. Immun. 1978, 22, 758-762.
75. Cline, T.D.; Karlsson, E.A.; Seufzer, B.J.; Schultz-Cherry, S. The hemagglutinin protein of highly pathogenic h5n1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages. J. Virol. 2013, 87, 1411-1419.
76. Tate, M.D.; Pickett, D.L.; van Rooijen, N.; Brooks, A.G.; Reading, P.C. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J. Virol. 2010, 84, 7569-7580.
77. GeurtsvanKessel, C.H.; Willart, M.A.; van Rijt, L.S.; Muskens, F.; Kool, M.; Baas, C.; Thielemans, K.; Bennett, C.; Clausen, B.E.; Hoogsteden H. C.; et al. Clearance of influenza virus from the lung depends on migratory langerin+cd11b- but not plasmacytoid dendritic cells. J. Exp. Med. 2008, 205, 1621-1634.
78. Tumpey, T.M.; Garcia-Sastre, A.; Taubenberger, J.K.; Palese, P.; Swayne, D.E.; Pantin-Jackwood, M.J.; Schultz-Cherry, S.; Solorzano, A.; Van Rooijen, N.; Katz J.M.; et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 2005, 79, 14933-14944.
79. McGill, J.; van Rooijen, N.; Legge, K.L. Protective influenza-specific cd8 t cell responses require interactions with dendritic cells in the lungs. J. Exp. Med. 2008, 205, 1635-1646.
80. Cao, W.; Taylor, A.K.; Biber, R.E.; Davis, W.G.; Kim, J.H.; Reber, A.J.; Chirkova, T.; de La Cruz, J.A.; Pandey, A.; Ranjan P.; et al. Rapid differentiation of monocytes into type i ifn-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection. J. Immunol. 2012, 189, 2257-2265.
81. Londrigan, S.L.; Tate, M.D.; Brooks, A.G.; Reading, P.C. Cell-surface receptors on macrophages and dendritic cells for attachment and entry of influenza virus. J. Leukoc. Biol. 2012, 92, 97-106.
82. Reading, P.C.; Miller, J.L.; Anders, E.M. Involvement of the mannose receptor in infection of macrophages by influenza virus. J. Virol. 2000, 74, 5190-5197.
83. Upham, J.P.; Pickett, D.; Irimura, T.; Anders, E.M.; Reading, P.C. Macrophage receptors for influenza a virus: Role of the macrophage galactose-type lectin and mannose receptor in viral entry. J. Virol. 2010, 84, 3730-3737.
84. Ng, W.C.; Liong, S.; Tate, M.D.; Irimura, T.; Denda-Nagai, K.; Brooks, A.G.; Londrigan, S.L.; Reading, P.C. The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus. J. Virol. 2013, 88, 1659-1672.
85. Wang, S.F.; Huang, J.C.; Lee, Y.M.; Liu, S.J.; Chan, Y.J.; Chau, Y.P.; Chong, P.; Chen, Y.M. Dc-sign mediates avian h5n1 influenza virus infection in cis and in trans. Biochem. Biophys. Res. Commun. 2008, 373, 561-566.
86. Londrigan, S.L.; Turville, S.G.; Tate, M.D.; Deng, Y.M.; Brooks, A.G.; Reading, P.C. N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza a viruses into cells expressing dc-sign or l-sign. J. Virol. 2011, 85, 2990-3000.
87. Hillaire, M.L.; Nieuwkoop, N.J.; Boon, A.C.; de Mutsert, G.; Vogelzang-van Trierum, S.E.; Fouchier, R.A.; Osterhaus, A.D.; Rimmelzwaan, G.F. Binding of dc-sign to the hemagglutinin of influenza a viruses supports virus replication in dc-sign expressing cells. PLoS One 2013, 8, e56164.
88. de Geus, E.D.; Tefsen, B.; van Haarlem, D.A.; van Eden, W.; van Die, I.; Vervelde, L. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken. Mol. Immunol. 2013, 56, 452-462.
89. Wiley, D.C.; Wilson, I.A.; Skehel, J.J. Structural identification of the antibody-binding sites of hong kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981, 289, 373-378.
90. Raymond, F.L.; Caton, A.J.; Cox, N.J.; Kendal, A.P.; Brownlee, G.G. Antigenicity and evolution amongst recent influenza viruses of h1n1 subtype. Nucleic Acids Res. 1983, 11, 7191-7203.
91. Skehel, J.J.; Stevens, D.J.; Daniels, R.S.; Douglas, A.R.; Knossow, M.; Wilson, I.A.; Wiley, D.C. A carbohydrate side chain on hemagglutinins of hong kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl. Acad. Sci. USA 1984, 81, 1779-1783.
92. Zhang, Y.; Zhu, J.; Li, Y.; Bradley, K.C.; Cao, J.; Chen, H.; Jin, M.; Zhou, H. Glycosylation on hemagglutinin affects the virulence and pathogenicity of pandemic h1n1/2009 influenza a virus in mice. PLoS One 2013, 8, e61397.
93. Throsby, M.; van den Brink, E.; Jongeneelen, M.; Poon, L.L.; Alard, P.; Cornelissen, L.; Bakker, A.; Cox, F.; van Deventer, E.; Guan, Y.; et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against h5n1 and h1n1 recovered from human igm+ memory b cells. PLoS One 2008, 3, e3942.
94. Han, T.; Marasco, W.A. Structural basis of influenza virus neutralization. Ann. N. Y. Acad. Sci. 2011, 1217, 178-190.
95. Ekiert, D.C.; Bhabha, G.; Elsliger, M.A.; Friesen, R.H.; Jongeneelen, M.; Throsby, M.; Goudsmit, J.; Wilson, I.A. Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324, 246-251.
96. Bautista, E.; Chotpitayasunondh, T.; Gao, Z.; Harper, S.A.; Shaw, M.; Uyeki, T.M.; Zaki, S.R.; Hayden, F.G.; Hui, D.S.; Kettner, J.D.; et al. Clinical aspects of pandemic 2009 influenza a (h1n1) virus infection. New Engl. J. Med. 2010, 362, 1708-1719.
97. Hancock, K.; Veguilla, V.; Lu, X.; Zhong, W.; Butler, E.N.; Sun, H.; Liu, F.; Dong, L.; DeVos, J.R.; Gargiullo, P.M.; et al. Cross-reactive antibody responses to the 2009 pandemic h1n1 influenza virus. New Engl. J. Med. 2009, 361, 1945-1952.
98. Itoh, Y.; Shinya, K.; Kiso, M.; Watanabe, T.; Sakoda, Y.; Hatta, M.; Muramoto, Y.; Tamura, D.; Sakai-Tagawa, Y.; Noda, T.; et al. In vitro and in vivo characterization of new swine-origin h1n1 influenza viruses. Nature 2009, 460, 1021-1025.
99. Miller, E.; Hoschler, K.; Hardelid, P.; Stanford, E.; Andrews, N.; Zambon, M. Incidence of 2009 pandemic influenza a h1n1 infection in england: A cross-sectional serological study. Lancet 2010, 375, 1100-1108.
100. O'Donnell, C.D.; Wright, A.; Vogel, L.N.; Wei, C.J.; Nabel, G.J.; Subbarao, K. Effect of priming with h1n1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic h1n1 virus. J. Virol. 2012, 86, 8625-8633.
101. Kim, J.I.; Lee, I.; Park, S.; Hwang, M.W.; Bae, J.Y.; Lee, S.; Heo, J.; Park, M.S.; Garcia-Sastre, A. Genetic requirement for hemagglutinin glycosylation and its implications for influenza a h1n1 virus evolution. J. Virol. 2013, 87, 7539-7549.
102. Wanzeck, K.; Boyd, K.L.; McCullers, J.A. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am. J. Respir. Crit. Care Med. 2011, 183, 767-773.
103. Eggink, D.; Goff, P.H.; Palese, P. Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyper-glycosylation of the globular head domain. J. Virol. 2013, doi:10.1128/JVI.02608-13.
104. de Vries, R.P.; Smit, C.H.; de Bruin, E.; Rigter, A.; de Vries, E.; Cornelissen, L.A.; Eggink, D.; Chung, N.P.; Moore, J.P.; Sanders, R.W.; et al. Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin. J. Virol. 2012, 86, 11735-11744.
105. Wang, C.C.; Chen, J.R.; Tseng, Y.C.; Hsu, C.H.; Hung, Y.F.; Chen, S.W.; Chen, C.M.; Khoo, K.H.; Cheng, T.J.; Cheng, Y.S.; et al. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc. Natl. Acad. Sci. USA 2009, 106, 18137-18142.
106. Thomas, P.G.; Keating, R.; Hulse-Post, D.J.; Doherty, P.C. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 2006, 12, 48-54.
107. Bui, H.H.; Peters, B.; Assarsson, E.; Mbawuike, I.; Sette, A. Ab and t cell epitopes of influenza a virus, knowledge and opportunities. Proc. Natl. Acad. Sci. USA 2007, 104, 246-251.
108. Brown, L.E.; White, D.O.; Jackson, D.C. Conservation of determinants for class ii-restricted t cells within site e of influenza virus hemagglutinin and factors influencing their expression. J. Virol. 1993, 67, 2887-2893.
109. Brown, L.E.; Ffrench, R.A.; Gawler, J.M.; Jackson, D.C.; Dyall-Smith, M.L.; Anders, E.M.; Tregear, G.W.; Duncan, L.; Underwood, P.A.; White, D.O. Distinct epitopes recognized by i-ad-restricted t-cell clones within antigenic site e on influenza virus hemagglutinin. J. Virol. 1988, 62, 305-312.
110. Thomas, D.B.; Hodgson, J.; Riska, P.F.; Graham, C.M. The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates cd4+ cytotoxic t cell recognition of endogenously processed antigen. J. Immunol. 1990, 144, 2789-2794.
111. Drummer, H.E.; Jackson, D.C.; Brown, L.E. Modulation of cd4+ t-cell recognition of influenza hemagglutinin by carbohydrate side chains located outside a t-cell determinant. Virology 1993, 192, 282-289.
112. Jackson, D.C.; Drummer, H.E.; Urge, L.; Otvos, L., Jr.; Brown, L.E. Glycosylation of a synthetic peptide representing a t-cell determinant of influenza virus hemagglutinin results in loss of recognition by cd4+ t-cell clones. Virology 1994, 199, 422-430.
113. Gambaryan, A.S.; Marinina, V.P.; Tuzikov, A.B.; Bovin, N.V.; Rudneva, I.A.; Sinitsyn, B.V.; Shilov, A.A.; Matrosovich, M.N. Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on h1n1 human influenza a virus grown in mdck cells and in embryonated eggs. Virology 1998, 247, 170-177.
114. Jayaraman, A.; Koh, X.; Li, J.; Raman, R.; Viswanathan, K.; Shriver, Z.; Sasisekharan, R. Glycosylation at asn91 of h1n1 haemagglutinin affects binding to glycan receptors. Biochem. J. 2012, 444, 429-435.
115. Ohuchi, M.; Ohuchi, R.; Sakai, T.; Matsumoto, A. Tight binding of influenza virus hemagglutinin to its receptor interferes with fusion pore dilation. J. Virol. 2002, 76, 12405-12413.
116. Gallagher, P.; Henneberry, J.; Wilson, I.; Sambrook, J.; Gething, M.J. Addition of carbohydrate side chains at novel sites on influenza virus hemagglutinin can modulate the folding, transport, and activity of the molecule. J. Cell Biol. 1988, 107, 2059-2073.
117. Matrosovich, M.; Zhou, N.; Kawaoka, Y.; Webster, R. The surface glycoproteins of h5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 1999, 73, 1146-1155.
118. Wang, W.; Lu, B.; Zhou, H.; Suguitan, A.L., Jr.; Cheng, X.; Subbarao, K.; Kemble, G.; Jin, H. Glycosylation at 158n of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated h5n1 a/vietnam/1203/2004 vaccine virus in ferrets. J. Virol. 2010, 84, 6570-6577.
119. Ohuchi, M.; Ohuchi, R.; Feldmann, A.; Klenk, H.D. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J. Virol. 1997, 71, 8377-8384.
120. Das, S.R.; Hensley, S.E.; David, A.; Schmidt, L.; Gibbs, J.S.; Puigbo, P.; Ince, W.L.; Bennink, J.R.; Yewdell, J.W. Fitness costs limit influenza a virus hemagglutinin glycosylation as an immune evasion strategy. Proc. Natl. Acad. Sci. USA 2011, 108, E1417-E1422.
121. Guo, D.; Shi, X.; Arledge, K.C.; Song, D.; Jiang, L.; Fu, L.; Gong, X.; Zhang, S.; Wang, X.; Zhang, L. A single residue within the v5 region of hiv-1 envelope facilitates viral escape from the broadly neutralizing monoclonal antibody vrc01. J. Biol. Chem. 2012, 287, 43170-43179.
122. van Gils, M.J.; Edo-Matas, D.; Bowles, E.J.; Burger, J.A.; Stewart-Jones, G.B.; Schuitemaker, H. Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum. J. Virol. 2011, 85, 8443-8448.
123. Sun, S.; Wang, Q.; Zhao, F.; Chen, W.; Li, Z. Prediction of biological functions on glycosylation site migrations in human influenza h1n1 viruses. PLoS One 2012, 7, e32119.
124. Hartley, C.A.; Reading, P.C.; Ward, A.C.; Anders, E.M. Changes in the hemagglutinin molecule of influenza type a (h3n2) virus associated with increased virulence for mice. Arch. Virol. 1997, 142, 75-88.
125. Reading, P.C.; Pickett, D.L.; Tate, M.D.; Whitney, P.G.; Job, E.R.; Brooks, A.G. Loss of a single n-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir. Res. 2009, 10, 117.
126. Hansen, S.; Holmskov, U. Lung surfactant protein d (sp-d) and the molecular diverted descendants: Conglutinin, cl-43 and cl-46. Immunobiology 2002, 205, 498-517.
127. Goh, B.C.; Rynkiewicz, M.J.; Cafarella, T.R.; White, M.R.; Hartshorn, K.L.; Allen, K.; Crouch, E.C.; Calin, O.; Seeberger, P.H.; Schulten, K.; et al. Molecular mechanisms of inhibition of influenza by surfactant protein d revealed by large-scale molecular dynamics simulation. Biochemistry 2013, 52, 8527-8538.
128. Krieger, E.; Joo, K.; Lee, J.; Raman, S.; Thompson, J.; Tyka, M.; Baker, D.; Karplus, K. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in casp8. Proteins 2009, 77, 114-122.